POWELL INDUSTRIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that POWELL INDUSTRIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Sep 30, 2018 | $448.72M | Dec 12, 2018 |
| FY2017 | Sep 30, 2017 | $395.91M | Dec 6, 2017 |
| FY2017 | Sep 30, 2016 | $565.24M | Dec 6, 2017 |
| FY2017 | Sep 30, 2015 | $661.86M | Dec 6, 2017 |
| FY2014 | Sep 30, 2014 | $647.81M | Dec 3, 2014 |
| FY2013 | Sep 30, 2013 | $674.77M | Dec 4, 2013 |
| FY2012 | Sep 30, 2012 | $717.19M | Dec 5, 2012 |
| FY2012 | Sep 30, 2011 | $562.40M | Dec 5, 2012 |
| FY2012 | Sep 30, 2010 | $550.69M | Dec 5, 2012 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.10B | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $1.01B | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $699.31M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $532.58M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $470.56M | Dec 6, 2023 |
| FY2022 | Sep 30, 2020 | $518.50M | Dec 6, 2022 |
| FY2021 | Sep 30, 2019 | $517.18M | Dec 8, 2021 |
| FY2020 | Sep 30, 2018 | $448.72M | Dec 9, 2020 |
| FY2019 | Sep 30, 2017 | $395.91M | Dec 5, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Sep 30, 2013 | $187.40M | Dec 4, 2013 |
| FY2013 | Jun 30, 2013 | $179.52M | Dec 4, 2013 |
| FY2013 | Mar 31, 2013 | $153.92M | Dec 4, 2013 |
| FY2013 | Dec 31, 2012 | $153.94M | Dec 4, 2013 |
| FY2012 | Sep 30, 2012 | $184.16M | Dec 5, 2012 |
| FY2012 | Jun 30, 2012 | $194.09M | Dec 5, 2012 |
| FY2012 | Mar 31, 2012 | $181.49M | Dec 5, 2012 |
| FY2012 | Dec 31, 2011 | $157.46M | Dec 5, 2012 |
| FY2012 | Sep 30, 2011 | $171.24M | Dec 5, 2012 |
| FY2012 | Jun 30, 2011 | $141.37M | Dec 5, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $93.53M | Nov 19, 2025 |
| FY2025 | Jun 30, 2025 | $87.90M | Nov 19, 2025 |
| FY2025 | Mar 31, 2025 | $83.43M | Nov 19, 2025 |
| FY2025 | Dec 31, 2024 | $59.52M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $80.43M | Nov 19, 2025 |
| FY2025 | Jun 30, 2024 | $81.74M | Nov 19, 2025 |
| FY2025 | Mar 31, 2024 | $62.72M | Nov 19, 2025 |
| FY2025 | Dec 31, 2023 | $48.19M | Nov 19, 2025 |
| FY2024 | Sep 30, 2023 | $51.98M | Nov 20, 2024 |
| FY2024 | Jun 30, 2023 | $42.67M | Nov 20, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $51.42M | Nov 19, 2025 |
| FY2025 | Jun 30, 2025 | $48.23M | Nov 19, 2025 |
| FY2025 | Mar 31, 2025 | $46.33M | Nov 19, 2025 |
| FY2025 | Dec 31, 2024 | $34.76M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $46.05M | Nov 19, 2025 |
| FY2025 | Jun 30, 2024 | $46.22M | Nov 19, 2025 |
| FY2025 | Mar 31, 2024 | $33.49M | Nov 19, 2025 |
| FY2025 | Dec 31, 2023 | $24.09M | Nov 19, 2025 |
| FY2024 | Sep 30, 2023 | $26.44M | Nov 20, 2024 |
| FY2024 | Jun 30, 2023 | $18.45M | Nov 20, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $217.86M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $178.77M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $62.52M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $7.22M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $1.02M | Dec 6, 2023 |
| FY2022 | Sep 30, 2020 | $19.07M | Dec 6, 2022 |
| FY2021 | Sep 30, 2019 | $11.46M | Dec 8, 2021 |
| FY2020 | Sep 30, 2018 | ($9.12M) | Dec 9, 2020 |
| FY2019 | Sep 30, 2017 | ($19.34M) | Dec 5, 2019 |
| FY2018 | Sep 30, 2016 | $15.76M | Dec 12, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $11.01M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $9.43M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $6.22M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $6.96M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $6.67M | Dec 6, 2023 |
| FY2022 | Sep 30, 2020 | $6.27M | Dec 6, 2022 |
| FY2021 | Sep 30, 2019 | $6.33M | Dec 8, 2021 |
| FY2020 | Sep 30, 2018 | $6.72M | Dec 9, 2020 |
| FY2019 | Sep 30, 2017 | $6.91M | Dec 5, 2019 |
| FY2018 | Sep 30, 2016 | $6.73M | Dec 12, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $95.40M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $84.89M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $78.81M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $70.83M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $67.22M | Dec 6, 2023 |
| FY2022 | Sep 30, 2020 | $67.66M | Dec 6, 2022 |
| FY2021 | Sep 30, 2019 | $69.95M | Dec 8, 2021 |
| FY2020 | Sep 30, 2018 | $66.77M | Dec 9, 2020 |
| FY2019 | Sep 30, 2017 | $61.52M | Dec 5, 2019 |
| FY2018 | Sep 30, 2016 | $74.92M | Dec 12, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $167.94M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $108.66M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $182.55M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | ($3.58M) | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | ($30.46M) | Dec 6, 2023 |
| FY2022 | Sep 30, 2020 | $72.39M | Dec 6, 2022 |
| FY2021 | Sep 30, 2019 | $68.76M | Dec 8, 2021 |
| FY2020 | Sep 30, 2018 | ($28.54M) | Dec 9, 2020 |
| FY2019 | Sep 30, 2017 | $36.82M | Dec 5, 2019 |
| FY2018 | Sep 30, 2016 | $74.91M | Dec 12, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $13.15M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $11.98M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $7.82M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $2.45M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $2.93M | Dec 6, 2023 |
| FY2022 | Sep 30, 2020 | $5.16M | Dec 6, 2022 |
| FY2021 | Sep 30, 2019 | $4.26M | Dec 8, 2021 |
| FY2020 | Sep 30, 2018 | $4.42M | Dec 9, 2020 |
| FY2019 | Sep 30, 2017 | $3.62M | Dec 5, 2019 |
| FY2018 | Sep 30, 2016 | $3.04M | Dec 12, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.11B | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $928.18M | Nov 19, 2025 |
| FY2024 | Sep 30, 2023 | $752.24M | Nov 20, 2024 |
| FY2023 | Sep 30, 2022 | $493.38M | Dec 6, 2023 |
| FY2022 | Sep 30, 2021 | $436.19M | Dec 6, 2022 |
| FY2021 | Sep 30, 2020 | $472.28M | Dec 8, 2021 |
| FY2020 | Sep 30, 2019 | $467.41M | Dec 9, 2020 |
| FY2019 | Sep 30, 2018 | $429.95M | Dec 5, 2019 |
| FY2018 | Sep 30, 2017 | $414.99M | Dec 12, 2018 |
| FY2017 | Sep 30, 2016 | $462.52M | Dec 6, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $468.21M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $445.11M | Nov 19, 2025 |
| FY2024 | Sep 30, 2023 | $407.22M | Nov 20, 2024 |
| FY2023 | Sep 30, 2022 | $196.17M | Dec 6, 2023 |
| FY2022 | Sep 30, 2021 | $134.97M | Dec 6, 2022 |
| FY2021 | Sep 30, 2020 | $165.65M | Dec 8, 2021 |
| FY2020 | Sep 30, 2019 | $168.26M | Dec 9, 2020 |
| FY2019 | Sep 30, 2018 | $128.31M | Dec 5, 2019 |
| FY2018 | Sep 30, 2017 | $93.69M | Dec 12, 2018 |
| FY2017 | Sep 30, 2016 | $127.20M | Dec 6, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $640.77M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $483.07M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $345.03M | Nov 19, 2025 |
| FY2025 | Sep 30, 2022 | $297.21M | Nov 19, 2025 |
| FY2024 | Sep 30, 2021 | $301.22M | Nov 20, 2024 |
| FY2023 | Sep 30, 2020 | $306.63M | Dec 6, 2023 |
| FY2022 | Sep 30, 2019 | $299.15M | Dec 6, 2022 |
| FY2021 | Sep 30, 2018 | $301.64M | Dec 8, 2021 |
| FY2020 | Sep 30, 2017 | $321.30M | Dec 9, 2020 |
| FY2019 | Sep 30, 2016 | $335.32M | Dec 5, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $6.13M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $1.00M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $1.00M | Nov 19, 2025 |
| FY2022 | Sep 30, 2022 | $1.00M | Dec 6, 2022 |
| FY2021 | Sep 30, 2021 | $1.00M | Dec 8, 2021 |
| FY2020 | Sep 30, 2020 | $1.00M | Dec 9, 2020 |
| FY2019 | Sep 30, 2019 | $1.00M | Dec 5, 2019 |
| FY2018 | Sep 30, 2018 | $1.00M | Dec 12, 2018 |
| FY2017 | Sep 30, 2017 | $1.00M | Dec 6, 2017 |
| FY2014 | Sep 30, 2014 | $1.00M | Dec 3, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $629.85M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $462.19M | Nov 19, 2025 |
| FY2024 | Sep 30, 2023 | $325.28M | Nov 20, 2024 |
| FY2023 | Sep 30, 2022 | $283.64M | Dec 6, 2023 |
| FY2022 | Sep 30, 2021 | $282.51M | Dec 6, 2022 |
| FY2021 | Sep 30, 2020 | $294.02M | Dec 8, 2021 |
| FY2020 | Sep 30, 2019 | $289.42M | Dec 9, 2020 |
| FY2019 | Sep 30, 2018 | $291.53M | Dec 5, 2019 |
| FY2018 | Sep 30, 2017 | $310.60M | Dec 12, 2018 |
| FY2017 | Sep 30, 2016 | $331.96M | Dec 6, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $450.74M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $315.33M | Nov 19, 2025 |
| FY2024 | Sep 30, 2023 | $245.88M | Nov 20, 2024 |
| FY2023 | Sep 30, 2022 | $101.95M | Dec 6, 2023 |
| FY2022 | Sep 30, 2021 | $114.31M | Dec 6, 2022 |
| FY2021 | Sep 30, 2020 | $160.22M | Dec 8, 2021 |
| FY2020 | Sep 30, 2019 | $118.64M | Dec 9, 2020 |
| FY2019 | Sep 30, 2018 | $36.58M | Dec 5, 2019 |
| FY2018 | Sep 30, 2017 | $68.36M | Dec 12, 2018 |
| FY2018 | Sep 30, 2016 | $97.72M | Dec 12, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Sep 30, 2022 | $0 | Dec 6, 2022 |
| FY2022 | Sep 30, 2021 | $400.0K | Dec 6, 2022 |
| FY2021 | Sep 30, 2020 | $800.0K | Dec 8, 2021 |
| FY2020 | Sep 30, 2019 | $1.20M | Dec 9, 2020 |
| FY2019 | Sep 30, 2018 | $1.60M | Dec 5, 2019 |
| FY2018 | Sep 30, 2017 | $2.00M | Dec 12, 2018 |
| FY2017 | Sep 30, 2016 | $2.40M | Dec 6, 2017 |
| FY2016 | Sep 30, 2015 | $2.80M | Dec 7, 2016 |
| FY2015 | Sep 30, 2014 | $3.20M | Dec 2, 2015 |
| FY2014 | Sep 30, 2013 | $3.60M | Dec 3, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 4 | Nov 19, 2025 |
| FY2025 | Jun 30, 2025 | 4 | Nov 19, 2025 |
| FY2025 | Mar 31, 2025 | 3 | Nov 19, 2025 |
| FY2025 | Dec 31, 2024 | 2 | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | 3 | Nov 19, 2025 |
| FY2025 | Jun 30, 2024 | 3 | Nov 19, 2025 |
| FY2025 | Mar 31, 2024 | 2 | Nov 19, 2025 |
| FY2025 | Dec 31, 2023 | 2 | Nov 19, 2025 |
| FY2024 | Sep 30, 2023 | 2 | Nov 20, 2024 |
| FY2024 | Jun 30, 2023 | 1 | Nov 20, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 4 | Nov 19, 2025 |
| FY2025 | Jun 30, 2025 | 3 | Nov 19, 2025 |
| FY2025 | Mar 31, 2025 | 3 | Nov 19, 2025 |
| FY2025 | Dec 31, 2024 | 2 | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | 3 | Nov 19, 2025 |
| FY2025 | Jun 30, 2024 | 3 | Nov 19, 2025 |
| FY2025 | Mar 31, 2024 | 2 | Nov 19, 2025 |
| FY2025 | Dec 31, 2023 | 1 | Nov 19, 2025 |
| FY2024 | Sep 30, 2023 | 2 | Nov 20, 2024 |
| FY2024 | Jun 30, 2023 | 1 | Nov 20, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 12.07M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | 11.99M | Nov 19, 2025 |
| FY2024 | Sep 30, 2023 | 11.86M | Nov 20, 2024 |
| FY2023 | Sep 30, 2022 | 12.59M | Dec 6, 2023 |
| FY2015 | Sep 30, 2015 | 12.10M | Dec 2, 2015 |
| FY2015 | Sep 30, 2014 | 12.03M | Dec 2, 2015 |
| FY2014 | Sep 30, 2013 | 11.97M | Dec 3, 2014 |
| FY2013 | Sep 30, 2012 | 11.92M | Dec 4, 2013 |
| FY2012 | Sep 30, 2011 | 11.75M | Dec 5, 2012 |
| FY2011 | Sep 30, 2010 | 11.68M | Dec 12, 2011 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $12.87M | Nov 19, 2025 |
| FY2025 | Sep 30, 2024 | $12.65M | Nov 19, 2025 |
| FY2025 | Sep 30, 2023 | $12.41M | Nov 19, 2025 |
| FY2024 | Sep 30, 2022 | $12.23M | Nov 20, 2024 |
| FY2023 | Sep 30, 2021 | $12.14M | Dec 6, 2023 |
| FY2022 | Sep 30, 2020 | $12.07M | Dec 6, 2022 |
| FY2021 | Sep 30, 2019 | $12.00M | Dec 8, 2021 |
| FY2020 | Sep 30, 2018 | $11.92M | Dec 9, 2020 |
| FY2019 | Sep 30, 2017 | $11.88M | Dec 5, 2019 |
| FY2018 | Sep 30, 2016 | $11.85M | Dec 12, 2018 |